The Profiles of Infantile Hemangiomas Patients
Downloads
Background: Infantile hemangiomas (IH) are the most prevalent benign tumors in children, predominantly in girls. Most IH cases do not require treatment due to spontaneous involution, but 10% of cases do require early treatment due to size, location, and complications. Purpose: This study tried to define the profile, clinical aspects, and therapy of IH in Dr. Zainoel Abidin General Hospital, Banda Aceh. Methods: A descriptive approach using a retrospective analysis employing secondary data from the outpatient clinic's patient registration book. This study included all new cases of infantile hemangioma at the outpatient clinic general hospital between 2013 and 2021. Result: A total of 105 patients were involved in this study. The majority of IH patients (59%) were under the age of one year, with 64 female patients (61%) making the most visits to the pediatric clinic in 2017, 2018, and 2019 (77.1%). The most prevalent clinical features of skin lesions were nodules in 69 individuals (65.7%), and the most common site was the facial region (13.3%) in 44 patients. In 20 individuals, a combination of propanolol and oral corticosteroids was used as the most effective treatment strategy (19% ). Conclusion: Infantile hemangiomas is the most frequently reported benign tumor in children. Females are more likely than males to develop IH. The majority of IH is minor and normally resolves on its own without therapy. However, certain rare kinds of IH require clinician attention and systematic treatment.
MacArthur K, Puttgen K. Vascular tumors. In: Kang S, Amagai M, Bruckner A, Enk A, Margolis D, McMichael A, et al, editor. Fitzpatrick's Dermatology. 9th ed. New York: McGraw Hill Medical; 2019. p. 2042–58.
Jung HI. Update on infantile hemangioma. Clini Exp Pediatr. 2021; 64(11): 539-72. doi:10.3345/cep2020.02061
Smith CJF, Friedlander SF, Guma M, Kavanaugh A, Chambers CD. Infantile hemangiomas: an updated review on risk factors, pathogenesis, and treatment. Birth Defects Res. 2017;109(11):809-15. doi: 10.1002/bdr2.1023.
Vivar, Mancini AJ. Infantile hemangiomas: an update on pathogenesis, associations, and management. Indian J Paediatr Dermatology. 2018;19: 293-303. doi: 10.4103/ijpd.IJPD_53_18
Seiffert A, Schneider M, Roessler J, Larisch K, Pfeiffer D. Incidence, treatment patterns, and health care costs of infantile hemangioma: results of a retrospective german database analysis. Pediatr Dermatol. 2017; 34(4): 450-7. doi : 10.1111/pde.13187
Qiu T, Yang K, Dai S, Chen S, Ji Y. Clinical features of segmental infantile hemangioma: a prospective study therapetic and clinical risk management. 2021; 17: 119-25. doi: 10.2147/TCRM.5291059
KIM JHS, Lam JM. Paediatrics: how to manage infantile hemangioma. Drugs in Context. 2021; 10: 1-13. doi: 10.7573/dic.2020-12-6
Tiemann L, Hein S. Infantile hemangioma: a review of current pharmacotherapy treatment and practice pearls. J Pediatr Pharmacol Ther. 2020;25(7):586-99. doi : 10.5863/1551-6776-25- 7.586
Wang C, et al. Quality of life in children with infantile hemangioma: a case control study. Health and Quality of Life Outcomes. 2017; 15: 221: 1-8
Cai Y, et al. Treatment pattern and outcomes in children with infantile hemangiomas: a retrospective observasional analysis. SAGE Open Medicine. 2021;9:1-8. doi: 10.1177/20503121211056844
Lydiawati E, Zulkarnain I. Infantile hemangioma: a retrospective study. BIKKK. 2020;32(1):21-6.
Higgins E, Glover M. Dermatoses and hemangiomas of infancy. In: Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D, editor. Rook's Textbook of Dermatology. 9th ed. New Jersey: WILEY Blackwell; 2016. p. 117.16-23.
Luca AC, Luca AC, Miron IC, Trandafir LM, Cojocaru E, PădureÅ£ IA, Trandafirescu MF, et al. Morphological, genetic and clinical correlations in infantile hemangiomas and their mimics. Rom J Morphol Embryol. 2020; 61(3): 687–695. doi: 10.47162/RJME.61.3.07
Krowchuk DP, Frieden IJ, Mancini AJ, Darrow DH, Blei F, Greene AK. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics. 2019; 143(1): e2018347 5.doi: 10.1542/ped.2018-3475
Kim J, Hang JW, Roh TS, Lee WJ. Oral propanolol in 23 infants with infantile hemangioma. Arch Plast Surgery. 2018; 43: 517- 24. doi: 10.5999/aps.2018.00318
Filoni A, Ambrogio F, Marco AD, Pacifico A, Bonamonte D. Topical betablockers in dermatologic therapy. Dermatologic Therapy. 2021; 34: 1-8. doi: 10.1111/dth.15016
Fei Q, Lin Y, Chen X. Treatment for infantile hemangioma: a systematic review and network meta-analysis. Eclinical Medicine. 2020; 26: 1- 5.doi:10.1016/j.eclinm.2020.1005
Copyright (c) 2023 Berkala Ilmu Kesehatan Kulit dan Kelamin
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.